Fifty physicians and scientists who review grant proposals at the Cancer Prevention and Research Institute of Texas have signed a strongly-worded statement in protest of recent Texas policies and laws that “severely undermine” public health.
Starting next week, NIH will require grantees to make more specific and timely disclosures of financial and resource contributions from outside sources.
Fifty years ago, the National Cancer Act was signed into law, providing the National Cancer Institute with new authority to expand discoveries in basic, clinical, and translational science, which included building a nationwide network of cancer centers to treat thousands of patients each day.
The Cancer History Project archives the histories of each of its contributing institutions, whether through profiles of institutions, interactive timeline, photo galleries, and more.
As we head into the third year of the global COVID-19 pandemic, everyone would just like it to be over.
As omicron infections and hospitalizations continue to peak in the U.S., a high-stakes battle over the national public health response is being fought in the rafters of political Washington.
If 2020 was a year of reckoning, 2021 was a year of action—and major milestones for The Cancer Letter and the cancer community.
In 1974, The Cancer Letter published a story listing seven proposed “laws” postulated by of one of oncology’s wise men, Emil J Freireich (The Cancer Letter, May 14, 1976).
In 1999, NCI recorded an oral history with Paul Marks, president and chief executive officer of Memorial Sloan Kettering Cancer Center from 1980-1999. Marks died April 28, 2021, at the age of 93.
In the morning of Nov. 10, 2020, Daniel V.T. Catenacci, director of the GI oncology program at the University of Chicago, did some trading, court documents say.
